![]() |
市場調查報告書
商品編碼
1237822
血糖監測設備市場規模、副產品、應用、分銷渠道、行業分析報告、區域展望、增長潛力、競爭對手市場份額和預測,2023-2032 年Self-monitoring Blood Glucose Devices Market Size, By Product, By Application, By Distribution Channel, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032 |
由於自我監控的不斷創新,預計自我監控市場將在 2023 年至 2032 年期間獲得巨大發展勢頭。
技術進步有望提供更簡單、更便攜、更方便的檢測設備,這些設備將在胰島素依賴型糖尿病患者中更受歡迎。
用於血糖監測的自我監測技術已成為主流,因為它們已被證明對糖尿病患者實用且方便。 據可靠報導,到2045年,全球將有超過7億人患有糖尿病。
總體而言,血糖儀行業在產品、應用、分銷渠道和區域方面存在細分。
按產品劃分,到 2032 年,血糖儀細分市場的複合年增長率預計將超過 14.5%。 這種增長主要是由於這些血糖儀在家庭環境中提供的便利。 主要製造商推出的新產品也將對該細分市場的擴張產生積極影響。
根據應用,到 2032 年,1 型糖尿病的價值預計將超過 24 億美元。 持續監測血糖水平以管理 1 型糖尿病患者劑量的需求日益增加,預計這將帶來可觀的市場回報。 根據該報告,2021 年將有超過 840 萬 1 型糖尿病患者。
按銷售渠道劃分,預計醫院藥房部門將在預計期間實現強勁增長。 糖尿病患病率的上升和老年人口的易感性增加以及因疾病管理而增加的醫院就診率預計將在未來幾年推動這一細分市場的採用。 醫院藥房中創新和先進的自我監測設備的可用性也將提升這一領域的增長潛力。
按地區劃分,到 2032 年,亞太地區自我監測設備市場的價值預計將超過 130 億美元。 該地區老年人口的增加和糖尿病患者的激增被認為為 SMBG 設備市場提供了有利可圖的增長機會。 此外,不斷推出新產品的行業巨頭的存在將支持該地區的擴張。 此外,增加醫療保健支出和政府為減輕糖尿病負擔所做的努力將進一步推動對 SMBG 設備的需求。
Self-monitoring Blood Glucose Monitoring Devices Market is anticipated to garner substantial momentum during 2023-2032 owing to the constant technological innovations in self-monitoring blood glucose devices. Advancements in technology offer easier, more portable, and more convenient testing devices that are anticipated to increase its popularity among insulin-dependent diabetes patients.
Self-monitoring technologies for blood glucose monitoring have become mainstream as they have proven to be pragmatic and convenient for diabetic population. According to credible reports, by 2045, more than 700 million people across the world will have diabetes.
Overall, the self-monitoring blood glucose monitoring devices industry is segmented in terms of product, application, distribution channel, and region.
Based on the product, the self-monitoring blood glucose meters segment is estimated to grow at over 14.5% CAGR through 2032. The growth will be majorly due to the convenience offered by these meters in home settings. Besides, the ongoing launch of new products by the major giants will also positively influence segment expansion.
Considering the application, the type 1 diabetes segment is anticipated to be valued at over $2.4 billion by 2032. The rising need for continuous monitoring of blood glucose levels among patients with type 1 diabetes to manage the dosing, will generate significant market revenue. As per reports, there were more than 8.4 million individuals living with type 1 diabetes in 2021.
By distribution channel, the hospital pharmacies segment is slated to register strong growth during the estimated timeframe. The increasing prevalence of diabetes and high susceptibility in the elderly population, coupled with a rise in hospital visits to manage the disease, will drive segment adoption in the ensuing years. Besides, the availability of innovative and advanced self-monitoring blood glucose devices at hospital pharmacies will stimulate the segment growth potential.
Regionally, the Asia Pacific self-monitoring blood glucose monitoring devices market is anticipated to be valued at over USD 13 billion by 2032. Growing geriatric population base and constantly surging cases of diabetes in the region will offer lucrative growth opportunities to the SMBG device market. The presence of some leading industry players, who are constantly working on launching new products, will support regional expansion. In addition, increasing healthcare expenditure and government initiatives to reduce the burden of the disease will further drive the SMBG device demand.